Form 4 · Filed May 14, 2026, 01:40 AM UTC
XENE/Xenon Pharmaceuticals Inc.
GANNON STEVEN — director
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
2 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| May 12, 2026 | M | other | 3,500 | $7 | $25,830 | 10,641 |
| May 12, 2026 | M | other | 3,500 | — | — | 0 |
Source: SEC EDGAR raw filing ↗ · Accession 0001193125-26-222369